ArcticZymes Technologies ASA (DE:B4V) has released an update.
Frank Mathias, Chairman of the Board at ArcticZymes Technologies, has increased his stake in the company by purchasing 2,000 shares at EUR 1.194 each. This strategic move highlights confidence in the company’s future by its leadership, potentially attracting investor interest. ArcticZymes Technologies, based in Norway, specializes in developing recombinant enzymes for various applications.
For further insights into DE:B4V stock, check out TipRanks’ Stock Analysis page.
